NO20053111D0 - Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering. - Google Patents

Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.

Info

Publication number
NO20053111D0
NO20053111D0 NO20053111A NO20053111A NO20053111D0 NO 20053111 D0 NO20053111 D0 NO 20053111D0 NO 20053111 A NO20053111 A NO 20053111A NO 20053111 A NO20053111 A NO 20053111A NO 20053111 D0 NO20053111 D0 NO 20053111D0
Authority
NO
Norway
Prior art keywords
cell
peptides
inhibit angiogenesis
invasion
migration
Prior art date
Application number
NO20053111A
Other languages
English (en)
Other versions
NO20053111L (no
Inventor
Robert J Ternansky
Andrew Mazar
Patricia L Gladstone
Amy L Allan
Sean M O'hare
Fernando Donate
Marian Plunkett
Stephanie A Hopkins
Won Hyung Yoon
Graham Parry
Original Assignee
Attenuon Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Attenuon Llc filed Critical Attenuon Llc
Publication of NO20053111D0 publication Critical patent/NO20053111D0/no
Publication of NO20053111L publication Critical patent/NO20053111L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20053111A 2002-11-25 2005-06-24 Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering. NO20053111L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42917402P 2002-11-25 2002-11-25
US47553903P 2003-06-02 2003-06-02
PCT/US2003/038175 WO2004047771A2 (en) 2002-11-25 2003-11-25 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof

Publications (2)

Publication Number Publication Date
NO20053111D0 true NO20053111D0 (no) 2005-06-24
NO20053111L NO20053111L (no) 2005-08-24

Family

ID=32397181

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20053111A NO20053111L (no) 2002-11-25 2005-06-24 Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.
NO20053112A NO20053112L (no) 2002-11-25 2005-06-24 Peptider som malsoker tumor- og endotelceller, sammensetninger og anvendelser av slike.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20053112A NO20053112L (no) 2002-11-25 2005-06-24 Peptider som malsoker tumor- og endotelceller, sammensetninger og anvendelser av slike.

Country Status (14)

Country Link
US (2) US7517855B2 (no)
EP (2) EP1594521A4 (no)
JP (2) JP2006514116A (no)
KR (2) KR20050097494A (no)
AU (2) AU2003297609A1 (no)
BR (2) BR0316523A (no)
CA (2) CA2507045A1 (no)
EA (2) EA200500870A1 (no)
HR (2) HRP20050584A2 (no)
MX (2) MXPA05005545A (no)
NO (2) NO20053111L (no)
NZ (2) NZ540363A (no)
PL (2) PL377701A1 (no)
WO (2) WO2004063213A2 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ540363A (en) * 2002-11-25 2007-11-30 Attenuon Llc Peptides which target tumor and endothelial cells, compositions and uses thereof
EP1766405A1 (en) * 2004-05-21 2007-03-28 MDS Inc. doing Business Through Its MDS Pharma Services Division Method of quantifying the cell-binding properties of a medical device
US20060078535A1 (en) * 2004-10-13 2006-04-13 The Regents Of The University Of Michigan Anticancer compounds and methods
WO2006083906A2 (en) * 2005-02-01 2006-08-10 Attenuon, Llc Compositions containing the anti-angiogenic phscn-peptide
CA2596357A1 (en) * 2005-02-01 2006-08-10 Attenuon, Llc Acid addition salts of ac-phscn-nh2
WO2008056207A1 (en) * 2006-11-08 2008-05-15 Chongxi Yu Transdermal delivery systems of peptides and related compounds
AU2016213759B2 (en) * 2006-11-08 2018-03-29 Chongxi Yu Transdermal delivery systems of peptides and related compounds
EP4067370A1 (en) 2009-05-08 2022-10-05 Chongxi Yu High penetration prodrug compositions of peptides and peptide related compounds
KR101228668B1 (ko) 2010-09-17 2013-01-31 가톨릭대학교 산학협력단 혈관신생 억제 활성을 갖는 펩타이드 및 이의 용도
US9625469B2 (en) 2011-06-23 2017-04-18 Board Of Regents, The University Of Texas System Identifying peptides at the single molecule level
US11435358B2 (en) 2011-06-23 2022-09-06 Board Of Regents, The University Of Texas System Single molecule peptide sequencing
CN102417540A (zh) * 2011-11-21 2012-04-18 中国药科大学 一种聚乙二醇修饰的整合素阻断剂hm-3及其应用
EP2846847B1 (en) * 2012-05-11 2020-03-25 C.P. Medical Corporation Biocompatible hydrogel treatments for retinal detachment
ES2664411T3 (es) 2013-03-15 2018-04-19 Suncor Energy Inc. Composiciones herbicidas
JP5970439B2 (ja) * 2013-09-20 2016-08-17 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
EP3543703A1 (en) 2014-09-15 2019-09-25 Board of Regents, The University of Texas System Improved single molecule peptide sequencing

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
WO1981003330A1 (en) * 1980-05-13 1981-11-26 Mitsubishi Chem Ind Cysteine derivative and production thereof
US4394519A (en) * 1982-01-19 1983-07-19 Research Corporation Amino acid blocking agents
GB8504253D0 (en) * 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
DE3815221C2 (de) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US5091176A (en) * 1988-11-02 1992-02-25 W. R. Grace & Co.-Conn. Polymer-modified peptide drugs having enhanced biological and pharmacological activities
US5443816A (en) 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5229366A (en) * 1990-10-23 1993-07-20 Fuji Photo Film Co., Ltd. Peptide-containing polyethylene glycol derivatives and application thereof
US5149801A (en) * 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5698155A (en) 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
US5639725A (en) 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
WO1996028206A1 (en) * 1995-03-14 1996-09-19 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosating unit
PT814861E (pt) * 1995-03-14 2002-09-30 Siemens Ag Pulverizador ultra-sonico com uma unidade de dosagem de precisao amovivel
US5618513A (en) * 1995-06-07 1997-04-08 Mallinckrodt Medical, Inc. Method for preparing radiolabeled peptides
MY147327A (en) * 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
JP2001501600A (ja) * 1996-09-10 2001-02-06 ザ バーナム インスティテュート 腫瘍ホーミング分子、それに由来する結合体、およびその使用方法
US6001965A (en) * 1996-11-21 1999-12-14 The Regents Of The University Of Michigan Anticancer compounds and methods
US6331409B1 (en) * 1996-11-21 2001-12-18 The Regents Of The University Of Michigan Methods and compositions for wound healing
US6025150A (en) * 1996-11-21 2000-02-15 The Regents Of The University Of Michigan Methods and compositions for wound healing
EP0897911B9 (en) * 1997-01-14 2004-12-01 Kaneka Corporation Process for producing cysteine derivatives
US5994309A (en) * 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
AU9477398A (en) * 1997-09-10 1999-03-29 Burnham Institute, The Methods of identifying molecules that home to angiogenic vasculature in tumors
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
AU5671099A (en) * 1998-08-14 2000-03-06 The Administrators Of The Tulane Eductional Fund Compounds having growth hormone releasing activity
ATE366936T1 (de) 2001-01-18 2007-08-15 Univ Michigan Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
NZ540363A (en) * 2002-11-25 2007-11-30 Attenuon Llc Peptides which target tumor and endothelial cells, compositions and uses thereof

Also Published As

Publication number Publication date
HRP20050584A2 (hr) 2006-04-30
EP1569678A2 (en) 2005-09-07
US20040162239A1 (en) 2004-08-19
EP1594521A2 (en) 2005-11-16
JP2006514116A (ja) 2006-04-27
BR0316523A (pt) 2005-10-18
WO2004063213A3 (en) 2005-03-03
MXPA05005469A (es) 2005-09-08
EA200500871A1 (ru) 2006-04-28
NZ540363A (en) 2007-11-30
NO20053111L (no) 2005-08-24
CA2506813A1 (en) 2004-07-29
MXPA05005545A (es) 2005-10-18
CA2507045A1 (en) 2004-06-10
WO2004047771A2 (en) 2004-06-10
KR20050097494A (ko) 2005-10-07
JP2006515866A (ja) 2006-06-08
WO2004063213A2 (en) 2004-07-29
WO2004047771A3 (en) 2005-09-15
AU2003298726A1 (en) 2004-08-10
PL377701A1 (pl) 2006-02-06
EP1569678A4 (en) 2008-01-02
US7517855B2 (en) 2009-04-14
EA200500870A1 (ru) 2006-04-28
KR20050096917A (ko) 2005-10-06
NO20053112L (no) 2005-08-05
PL377763A1 (pl) 2006-02-20
HRP20050585A2 (en) 2006-02-28
US20050020810A1 (en) 2005-01-27
NZ540889A (en) 2008-09-26
EP1594521A4 (en) 2008-01-09
AU2003297609A1 (en) 2004-06-18
NO20053112D0 (no) 2005-06-24
BR0316550A (pt) 2005-10-04

Similar Documents

Publication Publication Date Title
NO20053111D0 (no) Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.
DK1398322T3 (da) HASylerede polypeptider, især HASyleret erythropoietin
NO20053248D0 (no) Kerosenblanding.
NO20052248D0 (no) Svivelstykkesystem.
NO20052422D0 (no) Stabiliserte, fast tilstand polypeptidpartikler.
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
NO20051497D0 (no) Beta-laktamaseinhibitorprodrug.
ITMI20032170A1 (it) Tagliacimosse.
NO20023290D0 (no) Konstruksjon til lasting og lossing, samt anvendelse derav
ITTO20020204A0 (it) Terminale mobile specializzato.
NO20052979D0 (no) Propargyl-trifluormetoksy-amino-benzotiazolderivater.
ITPR20020006A1 (it) Struttura prefabbricata, in particolare per edilizia, e procedimento di realizzazione.
ES1052590Y (es) Quiosco-consigna.
ITRM20020216A1 (it) Interruttore di manovra-sezionatore.
NL1020380A1 (nl) Laadinrichting.
ITRM20020505A1 (it) Pasta ipersalina.
ITTO20021130A1 (it) Conduttore trasporto ctc.
ES1052029Y (es) Balin-proyectil.
ES1052945Y (es) Contraventana.
ES1051110Y (es) Caja-palet.
ES1052654Y (es) Cubitera.
ES1051605Y (es) Cromo-puzzle.
ES1051703Y (es) Potera.
ES1052011Y (es) Espetero.
ES1052938Y (es) Cantonera.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application